Suzhou, March 30, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business. | March 30, 2023
SUZHOU, China, March 30, 2023 /PRNewswire/ Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today. | March 30, 2023
SUZHOU, China, March 31, 2023 /PRNewswire/ Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended 31 December 2022. Business Highlights Dr. Youzhi Tong, founder, Chairman, and CEO of Kintor Pharma, commented, 2022 has been a challenging year for.
CHAIRMAN S STATEMENT 2022 was an important year for China to embark on a new journey towards its second centennial goals and fully building a modern socialist. | March 29, 2023